Published in Science on August 16, 2012
Colon Cancer Study of Fecal Samples in Shanghai, China | NCT01778595
Macrophage biology in development, homeostasis and disease. Nature (2013) 8.28
Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol (2013) 4.34
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer (2013) 4.02
Role of the microbiota in immunity and inflammation. Cell (2014) 3.43
Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe (2013) 3.21
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature (2015) 3.06
The microbiome and cancer. Nat Rev Cancer (2013) 2.86
The gut microbiome modulates colon tumorigenesis. MBio (2013) 2.45
Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe (2013) 2.22
Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. J Exp Med (2013) 2.18
The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila) (2014) 2.08
Microbes, microbiota, and colon cancer. Cell Host Microbe (2014) 2.06
Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice. Genome Biol (2013) 1.97
The colibactin warhead crosslinks DNA. Nat Chem (2015) 1.96
The gut microbiota and host health: a new clinical frontier. Gut (2015) 1.91
Cross-kingdom chemical communication drives a heritable, mutually beneficial prion-based transformation of metabolism. Cell (2014) 1.77
Interplay of host microbiota, genetic perturbations, and inflammation promotes local development of intestinal neoplasms in mice. J Exp Med (2014) 1.76
Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol (2012) 1.61
Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol (2013) 1.56
Melatonin reduces ulcerative colitis-associated local and systemic damage in mice: investigation on possible mechanisms. Dig Dis Sci (2013) 1.52
Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol (2014) 1.52
High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One (2013) 1.50
Genetic and Metabolic Signals during Acute Enteric Bacterial Infection Alter the Microbiota and Drive Progression to Chronic Inflammatory Disease. Cell Host Microbe (2016) 1.49
Interspecies interactions determine the impact of the gut microbiota on nutrient allocation in Drosophila melanogaster. Appl Environ Microbiol (2013) 1.48
Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer. Nat Commun (2014) 1.47
'Blooming' in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol (2013) 1.45
Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol (2014) 1.44
Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc Natl Acad Sci U S A (2013) 1.43
Epithelial calcineurin controls microbiota-dependent intestinal tumor development. Nat Med (2016) 1.42
Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans. Adv Immunol (2014) 1.38
The phosphopantetheinyl transferases: catalysis of a post-translational modification crucial for life. Nat Prod Rep (2014) 1.32
Microbial dysbiosis is associated with human breast cancer. PLoS One (2014) 1.28
Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome (2014) 1.27
The human microbiome: from symbiosis to pathogenesis. Annu Rev Med (2013) 1.25
Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol (2015) 1.23
Stochastic changes over time and not founder effects drive cage effects in microbial community assembly in a mouse model. ISME J (2013) 1.21
Bacterial oncogenesis in the colon. Future Microbiol (2013) 1.18
Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology (2013) 1.18
Antimicrobial peptides and gut microbiota in homeostasis and pathology. EMBO Mol Med (2013) 1.17
Dietary history contributes to enterotype-like clustering and functional metagenomic content in the intestinal microbiome of wild mice. Proc Natl Acad Sci U S A (2014) 1.17
Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells. Cancer Res (2013) 1.16
Comparative metabolomics and structural characterizations illuminate colibactin pathway-dependent small molecules. J Am Chem Soc (2014) 1.14
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. JAMA Oncol (2015) 1.12
Pathology of rodent models of intestinal cancer: progress report and recommendations. Gastroenterology (2013) 1.12
The gut microbiota in mouse models of inflammatory bowel disease. Front Cell Infect Microbiol (2014) 1.11
Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe (2013) 1.08
Cancer and the gut microbiota: an unexpected link. Sci Transl Med (2015) 1.08
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy. Oncoimmunology (2015) 1.07
Gastrointestinal malignancy and the microbiome. Gastroenterology (2014) 1.07
Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer. Immunity (2013) 1.07
Experimental approaches for defining functional roles of microbes in the human gut. Annu Rev Microbiol (2013) 1.06
Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol (2014) 1.06
Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis (2014) 1.04
Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis. Cell Rep (2015) 1.03
Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole. PLoS One (2013) 1.03
Colorectal cancer: looking for answers in the microbiota. Cancer Discov (2013) 1.02
Modeling the impact of antibiotic exposure on human microbiota. Sci Rep (2014) 1.01
Diversified pattern of the human colorectal cancer microbiome. Gut Pathog (2013) 1.01
Human symbionts inject and neutralize antibacterial toxins to persist in the gut. Proc Natl Acad Sci U S A (2016) 1.01
Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway. Oncogenesis (2014) 1.01
Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells. PLoS One (2013) 1.00
Mining the human gut microbiota for effector strains that shape the immune system. Immunity (2014) 1.00
Emerging roles of the microbiome in cancer. Carcinogenesis (2013) 1.00
Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin Exp Immunol (2015) 1.00
What's the damage? The impact of pathogens on pathways that maintain host genome integrity. Cell Host Microbe (2014) 1.00
The role of microbial amino acid metabolism in host metabolism. Nutrients (2015) 0.99
The gastrointestinal tumor microenvironment. Gastroenterology (2013) 0.99
Gut microbiota imbalance and colorectal cancer. World J Gastroenterol (2016) 0.99
Fusobacterium and Enterobacteriaceae: important players for CRC? Immunol Lett (2014) 0.98
The complex interplay between inflammation, the microbiota and colorectal cancer. Gut Microbes (2013) 0.98
Gut bacteria require neutrophils to promote mammary tumorigenesis. Oncotarget (2015) 0.97
Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease. Proc Natl Acad Sci U S A (2013) 0.97
Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. Genome Med (2016) 0.97
Regenerative inflammation: lessons from Drosophila intestinal epithelium in health and disease. Pathogens (2013) 0.96
Gut microbiome and metabolic diseases. Semin Immunopathol (2013) 0.96
Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol (2014) 0.96
Microbial imbalance and intestinal pathologies: connections and contributions. Dis Model Mech (2014) 0.96
The unexhausted potential of E. coli. Elife (2015) 0.96
Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int J Environ Res Public Health (2015) 0.96
Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells. J Exp Med (2015) 0.96
Gut microbiota and the paradox of cancer immunotherapy. Front Immunol (2014) 0.95
Influence of gut microbiota on subclinical inflammation and insulin resistance. Mediators Inflamm (2013) 0.95
Interplay between siderophores and colibactin genotoxin biosynthetic pathways in Escherichia coli. PLoS Pathog (2013) 0.94
Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect. Gut (2014) 0.94
The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol (2014) 0.94
Gut symbionts from distinct hosts exhibit genotoxic activity via divergent colibactin biosynthesis pathways. Appl Environ Microbiol (2015) 0.94
Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun (2015) 0.94
Gut microbiome and colorectal adenomas. Cancer J (2014) 0.94
Review: Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases. Arthritis Rheumatol (2016) 0.93
Microbiome-wide association studies link dynamic microbial consortia to disease. Nature (2016) 0.93
Functional profiling of the gut microbiome in disease-associated inflammation. Genome Med (2013) 0.93
Impaired selection of IgA and intestinal dysbiosis associated with PD-1-deficiency. Gut Microbes (2013) 0.93
Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis. Clin Infect Dis (2013) 0.93
The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol (2016) 0.93
Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS (2014) 0.92
Anatomical localization of commensal bacteria in immune cell homeostasis and disease. Immunol Rev (2014) 0.92
The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. Clin Transl Gastroenterol (2015) 0.92
Colon Macrophages Polarized by Commensal Bacteria Cause Colitis and Cancer through the Bystander Effect. Transl Oncol (2013) 0.91
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem (1998) 28.13
Inflammation and cancer: back to Virchow? Lancet (2001) 27.40
Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol (1999) 16.81
A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest (2007) 8.54
Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A (2003) 6.82
Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology (1998) 5.02
Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology (2004) 4.89
Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science (2006) 4.58
Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe (2010) 4.54
Intestinal inflammation and cancer. Gastroenterology (2011) 4.13
Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology (2005) 4.10
Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A (2010) 3.18
Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One (2009) 2.79
Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect (2001) 2.71
Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes (2010) 2.70
Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med (2002) 2.24
Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology (1998) 2.15
The 1995 Albert Lasker Medical Research Award. Helicobacter pylori. The etiologic agent for peptic ulcer. JAMA (1995) 1.94
Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect Immun (2009) 1.93
Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer. Oncogene (2010) 1.88
Genetically related Escherichia coli strains associated with Crohn's disease. Gut (2001) 1.61
Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli. FEMS Microbiol Lett (2007) 1.32
Interleukin 10-deficient mice exhibit defective colonic Muc2 synthesis before and after induction of colitis by commensal bacteria. Inflamm Bowel Dis (2004) 1.15
Expression of the antimicrobial peptide alpha-defensin/cryptdins in intestinal crypts decreases at the initial phase of intestinal inflammation in a model of inflammatory bowel disease, IL-10-deficient mice. Inflamm Bowel Dis (2010) 1.11
Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell (2007) 8.84
Gastric cancer originating from bone marrow-derived cells. Science (2004) 6.04
NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med (2009) 5.43
Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology (2004) 4.89
The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med (2010) 4.37
A core human microbiome as viewed through 16S rRNA sequence clusters. PLoS One (2012) 4.35
Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A (2005) 3.52
Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology (2003) 3.51
Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates. Am J Clin Nutr (2013) 3.28
DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest (2008) 3.17
Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science (2010) 2.99
The microbiome and cancer. Nat Rev Cancer (2013) 2.86
Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci U S A (2003) 2.86
Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One (2009) 2.79
Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes (2010) 2.70
CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol (2003) 2.70
No significant endothelial apoptosis in the radiation-induced gastrointestinal syndrome. Int J Radiat Oncol Biol Phys (2007) 2.68
Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis. Gut (2011) 2.68
High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One (2010) 2.60
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet (2011) 2.43
Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology (2010) 2.30
RNA expression analysis of formalin-fixed paraffin-embedded tumors. Lab Invest (2007) 2.25
Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med (2002) 2.24
KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer. Mol Cancer Ther (2009) 2.22
Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes. Blood (2011) 2.16
Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology (2005) 2.15
Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res (2008) 2.13
Crohn disease--associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae. J Clin Invest (2011) 2.10
NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity (2012) 2.07
BK calcium-activated potassium channels regulate circadian behavioral rhythms and pacemaker output. Nat Neurosci (2006) 2.01
CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res (2003) 2.00
Fusobacterium is associated with colorectal adenomas. PLoS One (2013) 1.99
Iron acquisition and regulation in Campylobacter jejuni. J Bacteriol (2004) 1.98
Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology (2003) 1.96
Constitutive nuclear factor-kappa B activity is required for central neuron survival. J Neurosci (2002) 1.95
Strain screen and haplotype association mapping of wheel running in inbred mouse strains. J Appl Physiol (1985) (2010) 1.88
Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans. Infect Immun (2002) 1.87
In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse. J Immunol (2004) 1.84
Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J Biol Chem (2006) 1.84
Gnotobiotic IL-10-/-;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. J Immunol (2007) 1.82
Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect Immun (2003) 1.81
Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut (2010) 1.77
Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect Immun (2004) 1.74
Listeria monocytogenes isolates from foods and humans form distinct but overlapping populations. Appl Environ Microbiol (2004) 1.73
In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect Immun (2004) 1.72
Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res (2003) 1.69
Mouse Paneth cell antimicrobial function is independent of Nod2. Gut (2013) 1.69
Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitis. J Immunol (2008) 1.68
L-fucose utilization provides Campylobacter jejuni with a competitive advantage. Proc Natl Acad Sci U S A (2011) 1.68
Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J (2012) 1.62
Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci (2009) 1.60
Identification of Campylobacter jejuni ATCC 43431-specific genes by whole microbial genome comparisons. J Bacteriol (2004) 1.59
STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood (2004) 1.58
Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res (2007) 1.58
Dual-association of gnotobiotic IL-10-/- mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm Bowel Dis (2007) 1.55
Major role for FeoB in Campylobacter jejuni ferrous iron acquisition, gut colonization, and intracellular survival. Infect Immun (2006) 1.52
Effects of experimental choices and analysis noise on surveys of the "rare biosphere". Appl Environ Microbiol (2009) 1.51
Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2011) 1.49
IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines. J Biol Chem (2002) 1.48
Characterization of the oxidative stress stimulon and PerR regulon of Campylobacter jejuni. BMC Genomics (2009) 1.47
Expression of leptospiral immunoglobulin-like protein by Leptospira interrogans and evaluation of its diagnostic potential in a kinetic ELISA. J Med Microbiol (2004) 1.44
A role for NF-kappa B subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock. J Immunol (2004) 1.41
Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. J Biol Chem (2005) 1.41
Oral contraceptives and Crohn's disease. Gut (2013) 1.39
Microbial colonization induces dynamic temporal and spatial patterns of NF-κB activation in the zebrafish digestive tract. Gastroenterology (2011) 1.39
Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect Immun (2005) 1.37
Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2 -/- C57BL6 x Sv129 Helicobacter pylori-infected mice. Am J Pathol (2007) 1.35
Specific strains of Escherichia coli are pathogenic for the endometrium of cattle and cause pelvic inflammatory disease in cattle and mice. PLoS One (2010) 1.34
Cochlear function in mice lacking the BK channel alpha, beta1, or beta4 subunits. J Biol Chem (2006) 1.34
NF-kappaB and the intestine: friend or foe? Inflamm Bowel Dis (2008) 1.33
Molecular diversity of a North Carolina wastewater treatment plant as revealed by pyrosequencing. Appl Environ Microbiol (2008) 1.32
Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell Microbiol (2007) 1.32
Conditional deletion of IkappaB-kinase-beta accelerates helicobacter-dependent gastric apoptosis, proliferation, and preneoplasia. Gastroenterology (2009) 1.31
Wild-type and interleukin-10-deficient regulatory T cells reduce effector T-cell-mediated gastroduodenitis in Rag2-/- mice, but only wild-type regulatory T cells suppress Helicobacter pylori gastritis. Infect Immun (2007) 1.31
Genetic heterogeneity in colorectal cancer associations between African and European americans. Gastroenterology (2010) 1.31
Think small: zebrafish as a model system of human pathology. J Biomed Biotechnol (2012) 1.30
Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease. PLoS One (2012) 1.28
Spatial distribution of Helicobacter spp. in the gastrointestinal tract of dogs. Helicobacter (2009) 1.28
Structure and regulon of Campylobacter jejuni ferric uptake regulator Fur define apo-Fur regulation. Proc Natl Acad Sci U S A (2012) 1.27
Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun (2006) 1.26
Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology (2005) 1.26
Liver transplantation as a cure for acute intermittent porphyria. Lancet (2004) 1.26
Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. Cancer Res (2009) 1.26
IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest Liver Physiol (2002) 1.25
NFIL3 is a regulator of IL-12 p40 in macrophages and mucosal immunity. J Immunol (2011) 1.25
Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. Mol Cancer (2010) 1.23
Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. Biochem Biophys Res Commun (2008) 1.23